Antitrust regulators at the Department of Justice are closing in on approving two massive vertical healthcare mergers in CVS-Aetna and Cigna-Express Scripts.
Both deals could get federal approval within the next few weeks, sources told The Wall Street Journal on Wednesday.
For CVS-Aetna, part of that approval could hinge on the companies selling off some of their assets, particularly in the Part D market where consumer advocacy groups have repeatedly raised concerns about consolidation within Medicare's drug benefit program. A Kaiser Family Foundation analysis earlier this year found that the two merged companies, plus UnitedHealth Group, would cover 71% of Part D plans.
